An ingredient long known for protecting eyesight could unlock new cancer-fighting potential in the human body. Zeaxanthin, found in leafy greens and available in over-the-counter supplements, appears to supercharge immune cells in ways that amplify existing cancer treatments.
Researchers found that zeaxanthin strengthens T cells, the immune system's frontline defenders against tumors. When paired with immunotherapy, the nutrient made the treatment more effective at halting cancer growth. The effect was strong enough in early testing to warrant human trials.
What makes this discovery particularly significant is zeaxanthin's accessibility. The nutrient is already in common vegetables and has been used safely in supplements for years, meaning there are no major safety hurdles to clear before testing it in patients. That's a sharp contrast to entirely new compounds that require extensive development.
Immunotherapy has transformed cancer care over the past decade by training the immune system to recognize and attack tumor cells. But results vary widely from patient to patient. Any tool that reliably boosts these treatments' effectiveness could help more people respond to therapy.
The research suggests zeaxanthin works by enhancing how T cells function at the molecular level. This mechanism could make it valuable not just for cancer but potentially for other conditions where immune response matters.
Scientists now plan to move forward with clinical trials in human patients, the critical next step for determining whether the lab findings translate into real therapeutic benefit. If the nutrient proves effective in people, it could offer an inexpensive way to improve outcomes for cancer patients already undergoing immunotherapy.
Comments